Antipsychotic medication adherence in schizophrenia

被引:134
作者
Byerly, Matthew J.
Nakonezny, Paul A.
Lescouflair, Emmeline
机构
[1] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Biostat & Clin Sci, Dallas, TX 75235 USA
关键词
D O I
10.1016/j.psc.2007.04.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
For individuals who have schizophrenia, adherence to medication is often poor, and stopping medication often has serious consequences. This article provides an update on recent literature regardmig the frequency, clinical and social impact, and clinical correlates of nonadherence to antipsychotic medication in schizophrenia. The authors then review published trials of interventions to improve adherence in schizophrenia.
引用
收藏
页码:437 / +
页数:17
相关论文
共 54 条
[1]   Systematic meta-review of depot antipsychotic drugs for people with schizophrenia [J].
Adams, CE ;
Fenton, MKP ;
Quraishi, S ;
David, AS .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 :290-299
[2]   Factors influencing relapse in the long-term course of schizophrenia [J].
Ayuso-Gutiérrez, JL ;
del Río Vega, JM .
SCHIZOPHRENIA RESEARCH, 1997, 28 (2-3) :199-206
[3]   A 2-YEAR PROSPECTIVE-STUDY OF TREATMENT COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA [J].
BUCHANAN, A .
PSYCHOLOGICAL MEDICINE, 1992, 22 (03) :787-797
[4]   A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia [J].
Byerly, M ;
Fisher, R ;
Whatley, K ;
Holland, R ;
Varghese, F ;
Carmody, T ;
Magouirk, B ;
Rush, AJ .
PSYCHIATRY RESEARCH, 2005, 133 (2-3) :129-133
[5]   A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder [J].
Byerly, MJ ;
Fisher, R ;
Carmody, T ;
Rush, AJ .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) :997-1001
[6]  
Cabeza IG, 2000, SCHIZOPHR RES, V41, P349
[7]   CONTROLLED TRIAL OF DEPOT FLUPHENAZINE IN OUTPATIENT SCHIZOPHRENICS [J].
CRAWFORD, R ;
FORREST, A .
BRITISH JOURNAL OF PSYCHIATRY, 1974, 124 (APR) :385-391
[8]   DEPOT ANTIPSYCHOTIC-DRUGS - PLACE IN THERAPY [J].
DAVIS, JM ;
METALON, L ;
WATANABE, MD ;
BLAKE, L .
DRUGS, 1994, 47 (05) :741-773
[9]  
Diaz E, 2004, J CLIN PSYCHIAT, V65, P354
[10]  
Diaz E, 2001, J PSYCHIATR NEUROSCI, V26, P325